Pyxis Oncology is trading 10.25% up at $3.12, with the move appearing mainly tied to broader risk-on sentiment alongside possible positioning around an estimated earnings release.
- The stock is rebounding from its August 11, 2026 close of $2.83, after that session’s 26.11% decline.
- No new company-specific announcement was identified in the company’s August 12, 2026 news releases.
- The Nasdaq is up 0.68%.